Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2010 Jan 5;74(1):33-41.
doi: 10.1212/WNL.0b013e3181c7197b. Epub 2009 Nov 25.

25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men

Y Slinin  1 , M L Paudel, B C Taylor, H A Fink, A Ishani, M T Canales, K Yaffe, E Barrett-Connor, E S Orwoll, J M Shikany, E S Leblanc, J A Cauley, K E Ensrud; Osteoporotic Fractures in Men (MrOS) Study Research Group
Collaborators, Affiliations
Multicenter Study

25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men

Y Slinin et al. Neurology. .

Abstract

Objective: To test the hypothesis that lower 25-hydroxyvitamin D [25(OH)D] levels are associated with a greater likelihood of cognitive impairment and risk of cognitive decline.

Methods: We measured 25(OH)D and assessed cognitive function using the Modified Mini-Mental State Examination (3MS) and Trail Making Test Part B (Trails B) in a cohort of 1,604 men enrolled in the Osteoporotic Fractures in Men Study and followed them for an average of 4.6 years for changes in cognitive function.

Results: In a model adjusted for age, season, and site, men with lower 25(OH)D levels seemed to have a higher odds of cognitive impairment, but the test for trend did not reach significance (impairment by 3MS: odds ratio [OR] 1.84, 95% confidence interval [CI] 0.81-4.19 for quartile [Q] 1; 1.41, 0.61-3.28 for Q2; and 1.18, 0.50-2.81 for Q3, compared with Q4 [referent group; p trend = 0.12]; and impairment by Trails B: OR 1.66, 95% CI 0.98-2.82 for Q1; 0.96, 0.54-1.69 for Q2; and 1.30, 0.76-2.22 for Q3, compared with Q4 [p trend = 0.12]). Adjustment for age and education further attenuated the relationships. There was a trend for an independent association between lower 25(OH)D levels and odds of cognitive decline by 3MS performance (multivariable OR 1.41, 95% CI 0.89-2.23 for Q1; 1.28, 0.84-1.95 for Q2; and 1.06, 0.70-1.62 for Q3, compared with Q4 [p = 0.10]), but no association with cognitive decline by Trails B.

Conclusion: We found little evidence of independent associations between lower 25-hydroxyvitamin D level and baseline global and executive cognitive function or incident cognitive decline.

PubMed Disclaimer

Figures

None
Figure Road map of 1,606 participants with baseline 25(OH)D levels 25(OH)D = 25-hydroxyvitamin D; 3MS = Modified Mini-Mental State Examination; Trails B = Trail Making Test Part B.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Gloth FM III, Gundberg CM, Hollis BW, Haddad JG Jr, Tobin JD. Vitamin D deficiency in homebound elderly persons. JAMA 1995;274:1683–1686. - PubMed
    1. Goldray D, Mizrahi-Sasson E, Merdler C, et al. Vitamin D deficiency in elderly patients in a general hospital. J Am Geriatr Soc 1989;37:589–592. - PubMed
    1. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998;338:777–783. - PubMed
    1. Zadshir A, Tareen N, Pan D, Norris K, Martins D. The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis 2005;15:S5–S101. - PubMed
    1. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266–281. - PubMed

Publication types

Grants and funding